This is an ongoing investigation and discussion about how the misuse of Halcion (off-label) as a dental sedative has severely disrupted (to say the least) my daughter’s and, therefore, my life.
The abuse of Halcion by her dentist, after she suffered a traumatic head injury, has snowballed from one abuse after another of psychoactive drugs forced upon her by the collective consensus of a system manipulated by the pharmaceutical industry.
Now it’s ABILIFY, which is known, see below, to CAUSE OR WORSEN psychosis, as are many other psychotropic drugs, something which the medical and “social” community can’t seem to wrap their own robbed brains around.
http://journals.lww.com/intclinpsychopharm/Abstract/2004/01000/Aripiprazole_possibly_worsens_psychosis.9.aspx
International Clinical Psychopharmacology:
January 2004 – Volume 19 – Issue 1 – pp 45-48
Case Reports
Aripiprazole possibly worsens psychosis
Ramaswamy, Srirama b c; Vijay, Dewanb c; William, Marcila c; Pirzada Sattar, S.a c; Praveen, Fernandesa c; Petty, Fredericka c
Abstract
Aripirazole is a novel antipsychotic that functions as a partial agonist at the dopamine D2 receptor and, thus, might theoretically worsen psychosis. We report a series of four clinical cases of exacerbation of psychosis related to initiation of aripiprazole therapy. Cases 1 and 2 demonstrated the worsening of psychosis following initiation of aripiprazole (15-30 mg daily) while tapering off the previous atypical antipsychotic. Cases 3 and 4 demonstrated worsening of psychosis following the addition of aripiprazole (15-30 mg daily) to an atypical antipsychotic. In two out of the four cases, discontinuation of arpiprazole resulted in improvement of psychotic symptoms. Although the cases presented are suggestive of a relationship between initiation of aripiprazole therapy and worsening of psychosis, further research is needed to clarify any potential association.
Summary:
Paragraphs three through five read: “The patient was started on duloxetine [Cymbalta] 7 months before. Ten days prior to admission, her primary care physician had started her on aripiprazole [Abilify] (2 mg/day) for augmentation. She denied a history of psychotic symptoms and drug or alcohol abuse as well as a family history of psychosis.”
“Three days after starting aripiprazole [Abilify] , Ms. L reported auditory hallucinations. She was paranoid regarding her ex-husband. She described command hallucinations from the devil, who meant to harm her, and could also hear God’s voice encouraging her not to listen to the devil. She experienced concurrent onset of suicidal ideation with no plan. She was fully oriented, with no evidence of confusion. Aripiprazole was reduced to 1 mg/day, which led to amelioration of her hallucinations. However, her suicidal thoughts and paranoid beliefs persisted.
The psychiatric consultant decided to discontinue aripiprazole, leading to rapid and complete resolution of the patient’s psychotic symptoms and suicidal ideation. Her ongoing depression was managed with duloxetine (60 mg twice daily).
SSRI Stories note: Abilify is an antipsychotic which, at low doses, acts as an antidepressant on the serotonin neurotransmitters. This is the same mechanism as the SSRI antidepressants. Raising serotonin levels too high can cause psychosis. Psychosis is listed as a side effect in the Physicians Desk Reference for all antidepressants.
http://ajp.psychiatryonline.org/cgi/content/full/167/12/1535-a
Am J Psychiatry 167:1535-a-1536, December 2010
doi: 10.1176/appi.ajp.2010.10020238
© 2010 American Psychiatric Association
Evidence is mounting that antipsychotic drugs worsen symptoms with long-term use and also make it very difficult to get off them. Many now say that only evidence of substantial benefit justifies using antipsychotic drugs and if use is justified, the lowest dose for the shortest duration is recommended.
Robert Whitaker explains this and alternatives to drug treatment in an interview on Salon.com
http://www.salon.com/books/feature/2010/04/27/interview_whitaker_anatomy_of_an_epidemic
Also this note:
http://www.healthyplace.com/thought-disorders/schizophrenia-treatment/how-effective-are-antipsychotics-in-treating-schizophrenia/menu-id-64/
Some doubts have been raised about the long-term effectiveness of antipsychotics because two large international World Health Organization studies found individuals diagnosed with schizophrenia tend to have better long-term outcomes in developing countries (where there is lower availability and use of antipsychotics) than in developed countries. The reasons for the differences are not clear, however, and various explanations have been suggested.
Some argue that the evidence for antipsychotics from withdrawal-relapse studies may be flawed because they do not take into account that antipsychotics may sensitize the brain and provoke psychosis if discontinued. Evidence from comparison studies indicates that at least some individuals recover from psychosis without taking antipsychotics and may do better than those that do take antipsychotics. Some argue that, overall, the evidence suggests that antipsychotics only help if they are used selectively and are gradually withdrawn as soon as possible.
Atypical vs Typical Antipsychotic Medications for Treatment of Schizophrenia.
And this short video by a former spokesperson for Abilify certainly raises concerns about the drug’s safety.
Brainrobber's Blog 